Cargando…
Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Anthracyclines are chemotherapeutic agents widely used to treat a variety of cancers, and these drugs have revolutionized our management of cancer patients. The dose-dependent cardiotoxicity of anthracyclines, however, remains one of the leading causes of chemotherapy treatment-associated mortality...
Autores principales: | Ding, Yonghe, Du, Ke, Niu, Yu-Juan, Wang, Yong, Xu, Xiaolei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365594/ https://www.ncbi.nlm.nih.gov/pubmed/35965684 http://dx.doi.org/10.1155/2022/5818612 |
Ejemplares similares
-
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011) -
Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022) -
Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
por: Moossavi, Maryam, et al.
Publicado: (2023) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity
por: Ma, Xiao, et al.
Publicado: (2020)